A Study Comparing IBI362 vs Semaglutide in Chinese Adults With Early Type 2 Diabetes and Obesity
Clinical trial NCT06184568 · COMPLETED
Trial details
- NCT number
- NCT06184568
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-29
- Primary completion
- 2025-09-17
- Enrollment
- 349
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.